Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer

@article{Freudenberg2011ClinicalAO,
  title={Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer},
  author={Lutz Stefan Freudenberg and Walter Jentzen and Alexander R. Stahl and Andreas Bockisch and Sandra Julia Rosenbaum-Krumme},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2011},
  volume={38},
  pages={48-56}
}
124I-PET/CT has a high clinical potential in patients with differentiated thyroid cancer (DTC). Two aspects deserve special mention: staging of recurrent or residual disease and pretherapy dosimetry. Used in combination 124I-PET and CT allows foci of highly specific 124I uptake to be localized with a low radiation dose, which is specifically important in pretherapy diagnostics. In addition in the combination of FDG-PET and CT non-iodine-avid lesions may be detected and may be discriminated from… CONTINUE READING